RZNOMICS

rznomics-logo

This is a biotechnology company founded by professor Lee Sung-wook's lab They are working on the development of gene therapy products for liver cancer through the development of gene therapy products. It was selected by the TIPS program and was recognized for excellence in technology.

#SimilarOrganizations #People #Financial #Website #More

RZNOMICS

Industry:
Biopharma Biotechnology

Founded:
2017-08-01

Address:
Gwangju, Kwangju-jikhalsi, South Korea

Country:
South Korea

Website Url:
http://www.rznomics.com

Total Employee:
11+

Status:
Active

Contact:
+82 62-974-2905

Total Funding:
59.7 B KRW

Technology used in webpage:
IPhone / Mobile Compatible SPF Mobile Non Scaleable Content Nginx Microsoft Exchange Online Office 365 Mail UNPKG Korea Telecom


Similar Organizations

faze-medicines-logo

Faze Medicines

Faze Medicines is a biotechnology company.

ge-holdings-japan-logo

GE Holdings Japan

GE Holdings is a biotechnology based company.

lion-tcr-logo

Lion TCR

Lion TCR is a clinical-stage biotechnology company.

repertoire-genesis-logo

Repertoire Genesis

Repertoire Genesis is a biotechnology company.

Current Employees Featured

not_available_image

Seongwook Lee
Seongwook Lee CEO & Founder @ Rznomics
CEO & Founder
2017-09-01

Founder


not_available_image

Seongwook Lee

Investors List

aon-corporation_image

Aon plc

Aon plc investment in Series C - Rznomics

sbi-investment-korea_image

SBI Investment Korea

SBI Investment Korea investment in Series C - Rznomics

quad-ventures_image

Quad Ventures

Quad Ventures investment in Series C - Rznomics

shinhan-venture-investment_image

Shinhan Venture Investment

Shinhan Venture Investment investment in Series C - Rznomics

ibk-capital-951b_image

IBK Capital

IBK Capital investment in Series C - Rznomics

partners-investment_image

Partners Investment

Partners Investment investment in Series C - Rznomics

utc-investment-co_image

UTC Investment Co.

UTC Investment Co. investment in Series C - Rznomics

korean-development-bank_image

Korea Development Bank

Korea Development Bank investment in Series C - Rznomics

synergy-ib-investment_image

Synergy IB Investment

Synergy IB Investment investment in Series B - Rznomics

partners-investment_image

Partners Investment

Partners Investment investment in Series B - Rznomics

Official Site Inspections

http://www.rznomics.com

  • Host name: 183.111.183.33
  • IP address: 183.111.183.33
  • Location: South Korea
  • Latitude: 37.5112
  • Longitude: 126.9741
  • Timezone: Asia/Seoul

Loading ...

More informations about "Rznomics"

Rznomics - Crunchbase Company Profile & Funding

Rznomics is a biotechnology company. This is a biotechnology company founded by professor Lee Sung-wook's lab They are working on the development of …See details»

Rznomics Inc. - LinkedIn

Rznomics' Strategy for Investor Confidence Ahead of Special Technology-Based IPO "Rational evidence and global competitiveness are essential." "Without deep science, supported by …See details»

Rznomics 2025 Company Profile: Valuation, Funding & Investors

When was Rznomics founded? Rznomics was founded in 2017. Where is Rznomics headquartered? Rznomics is headquartered in Yongin, South Korea. What is the size of …See details»

Rznomics Co., Ltd. - Drug pipelines, Patents, Clinical trials - Synapse

Explore Rznomics Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, 24 news, and 6 literature, Disease Domain:Nervous System Diseases, Neoplasms, …See details»

Rznomics - 2025 Company Profile, Funding & Competitors - Tracxn

Mar 29, 2025 Rznomics is a series C company based in Yongin si (South Korea), founded in 2017 by Seong-Wook Lee. It operates as a Developer of drugs for anti-cancer and refractory …See details»

Rznomics Company Profile - Office Locations, Competitors ... - Craft

Rznomics $10.28 m in total funding,. See insights on Rznomics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»

Rznomics - Contacts, Employees, Board Members, Advisors

Rznomics is a biotechnology company. Experience the new Crunchbase, powered by AI . Experience the new Crunchbase, powered by AISee details»

RZNOMICS Inc. received FDA approval to initiate clinical …

SEONGNAM, South Korea, Oct. 25, 2022 /PRNewswire/ -- Rznomics Inc., a South Korea based biopharmaceutical company specialized in the development of RNA-based gene therapeutics, …See details»

Rznomics Inc. - VentureRadar

Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»

Rznomics Enters Global Licensing Agreement with Eli Lilly for RNA ...

5 days ago Rznomics is a clinical-stage biopharmaceutical company based in South Korea focused on developing RNA-based gene therapies. The company's proprietary trans-splicing …See details»

SK pharmteco and Rznomics Explore Collaboration for RNA-based …

SEONGNAM, South Korea, Aug. 5, 2024 – SK pharmteco, a global contract development, manufacturing, and analytical testing organization serving both the small molecule and cell & …See details»

Rznomics

6 days ago Rznomics Secures KRW 20.3 Billion in Pre-IPO Funding, Bringing Total Investment to KRW 81.2 Billion. RNA-based gene therapy developer Rznomics announced on the 23rd …See details»

Rznomics - Funding, Financials, Valuation & Investors - Crunchbase

How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»

Charles River and Rznomics Announce RNA-based Anticancer …

Jan 18, 2023 WILMINGTON, Mass.--(BUSINESS WIRE)--Jan. 18, 2023-- Charles River Laboratories International, Inc. (NYSE: CRL) and Rznomics Inc., a South Korea-based …See details»

Rznomics Enters Global Licensing Agreement with Eli Lilly for RNA ...

5 days ago Rznomics Inc., a South Korea-based biopharmaceutical company specializing in RNA-based therapeutics, announced today that it has entered into a strategic global research …See details»

Charles River and Rznomics Ink RNA-Based Anticancer Gene …

Jan 20, 2023 Charles River Laboratories (CRL) International and Rznomics Inc. have announced a contract development and manufacturing organization (CDMO) partnership …See details»

Rznomics

Jan 20, 2025 RNA-based gene therapy developer Rznomics announced on the 23rd that it has successfully raised KRW 20.3 billion in a Pre-IPO funding round. The round was led by KB …See details»

rznomics.com Reviews | check if site is scam or legit| Scamadviser

Check rznomics.com with our free review tool and find out if rznomics.com is legit and reliable. Need advice? Report scams Check Scamadviser! Report a Scam Help & Info API & Data …See details»

Rznomics

SEONGNAM, South Korea, Aug. 5, 2024 /PRNewswire/ -- SK pharmteco, a global contract development, manufacturing, and analytical testing organization serving both the small …See details»

Rznomics

SEONGNAM, South Korea, May 19, 2023 /PRNewswire/ -- Rznomics Inc., a South Korea based biopharmaceutical company specialized in the development of RNA-based gene therapeutics, …See details»

linkstock.net © 2022. All rights reserved